Patents by Inventor Benjamin J. Feldman

Benjamin J. Feldman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220386906
    Abstract: An analyte sensor including an antiglycolytic agent or a precursor thereof and a chelating agent that stabilizes the antiglycolytic agent positioned proximate to the working electrode of the sensor. Also provided are systems and methods of using the electrochemical analyte sensors in analyte monitoring.
    Type: Application
    Filed: August 5, 2022
    Publication date: December 8, 2022
    Applicant: Abbott Diabetes Care, Inc.
    Inventors: Tianmei OUYANG, Zenghe LIU, Hyun CHO, Benjamin J. FELDMAN
  • Publication number: 20220386911
    Abstract: An analyte sensor and methods and systems related thereto, where at least one or more of a lower portion of a sensor tail substrate, at least one electrode, a sensing element, a membrane, and an optional non-electrochemical functional layer comprise an antimicrobial quality. Asymmetric, double-sided adhesive binders suitable for adhering the analyte sensor to a skin surface comprising a non-woven scrim, a first pressure-sensitive adhesive layer, a second pressure-sensitive adhesive layer. Overbandages comprising a vapor-permeable backing, an aperture to circumferentially surround a sensor housing, a contact adhesive layer, first and second peelable release liners, and a third peelable release liner disposed upon an anchoring adhesive strip of the contact adhesive layer.
    Type: Application
    Filed: August 16, 2022
    Publication date: December 8, 2022
    Applicant: Abbott Diabetes Care, Inc.
    Inventors: Jonathan D. MCCANLESS, Udo HOSS, Benjamin J. FELDMAN, Frank David FUJIMOTO, Steven T. MITCHELL
  • Publication number: 20220389475
    Abstract: NADP-dependent oxidoreductase compositions, and electrodes, sensors and systems that include the same. Analyte sensors include an electrode having a sensing layer disposed thereon, the sensing layer comprising a polymer and an enzyme composition distributed therein. The enzyme composition includes nicotinamide adenine dinucleotide phosphate (NAD(P)+) or derivative thereof; an NAD(P)+-dependent dehydrogenase; an NAD(P)H oxidoreductase; and an electron transfer agent comprising a transition metal complex.
    Type: Application
    Filed: August 10, 2022
    Publication date: December 8, 2022
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Tianmei OUYANG, Benjamin J. FELDMAN
  • Publication number: 20220386910
    Abstract: Methods and analyte sensors including at least a first working electrode having a first active area thereon, and performing a dip coating operation to deposit a bilayer membrane upon the first working electrode and the first active area. The bilayer may include an inner layer having a first membrane polymer and an outer layer having a second membrane polymer, the first membrane polymer and the second membrane polymer differing from one another. The dip coating operation may comprise one or more first dips in a first membrane formulation to form the inner layer of the bilayer membrane and one or more second dips in a second membrane formulation to form the outer layer of the bilayer membrane upon the inner layer.
    Type: Application
    Filed: August 11, 2022
    Publication date: December 8, 2022
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Stephen OJA, Tianmei Ouyang, Hyun Cho, Lam N. Tran, Benjamin J. Feldman, Mark K. Sloan, AShwin Kumar, Namvar Kiaie, Michael R. Love
  • Patent number: 11439326
    Abstract: An analyte sensor including an antiglycolytic agent or a precursor thereof and a chelating agent that stabilizes the antiglycolytic agent positioned proximate to the working electrode of the sensor. Also provided are systems and methods of using the electrochemical analyte sensors in analyte monitoring.
    Type: Grant
    Filed: January 21, 2019
    Date of Patent: September 13, 2022
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Tianmei Ouyang, Zenghe Liu, Hyun Cho, Benjamin J. Feldman
  • Publication number: 20220202327
    Abstract: The present disclosure provides an analyte sensor for use in detecting various analytes. In certain embodiments, an analyte-responsive active area of a presently disclosed analyte sensor includes two or more enzyme systems for detecting the analyte. The present disclosure further provides methods for detecting various analytes using the disclosed analyte sensors.
    Type: Application
    Filed: January 3, 2022
    Publication date: June 30, 2022
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Zenghe Liu, Benjamin J. Feldman
  • Publication number: 20220205944
    Abstract: The present disclosure provides an analyte sensor for use in detecting aspartate and/or asparagine. In certain embodiments, an aspartate-responsive active site of a presently disclosed analyte sensor includes an aspartate oxidase disposed upon a surface of a working electrode. In certain embodiments, an asparagine-responsive active site of a presently disclosed analyte sensor includes an enzyme system comprising an aspartate oxidase and an asparaginase disposed upon a surface of a working electrode. The present disclosure further provides methods for detecting aspartate and/or asparagine using the disclosed analyte sensors.
    Type: Application
    Filed: December 23, 2021
    Publication date: June 30, 2022
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Zenghe LIU, Barry S. Kreutz, Yagya Raj Ojha, Benjamin J. Feldman, Thomas P. Leary
  • Publication number: 20220192597
    Abstract: Apparatus, methods, and systems for detecting alcohol concentrations of an individual, such as an in vivo alcohol concentrations of an individual. The system can include an analyte sensor and a reader. The reader can receive a signal from the analyte sensor. The reader can determine blood alcohol concentration, in part, based on the received signal from the analyte sensor. The reader can also detect an adverse condition of the analyte sensor, and/or output an indication based on the detected adverse condition.
    Type: Application
    Filed: December 20, 2021
    Publication date: June 23, 2022
    Applicant: ABBOTT DIABETES CARE INC.
    Inventor: Benjamin J. Feldman
  • Publication number: 20220192552
    Abstract: Apparatus, methods, and systems for detecting alcohol concentrations of an individual, such as an in vivo alcohol concentrations of an individual. The blood alcohol concentration can be determined based on the peak signal width of the signal received from an analyte sensor.
    Type: Application
    Filed: December 20, 2021
    Publication date: June 23, 2022
    Applicant: ABBOTT DIABETES CARE INC.
    Inventor: Benjamin J. Feldman
  • Publication number: 20220192550
    Abstract: Analyte sensor comprises an electrode layer having an elongate body comprising a proximal end and a distal end. The electrode layer includes a first active working electrode area, a second electrode portion, and at least one gap electrically separating the first active working electrode portion and the second electrode portion. The first active working electrode area comprises at least one sensing spot with at least one analyte responsive enzyme disposed thereupon. Additional analyte sensors disclosed.
    Type: Application
    Filed: June 15, 2021
    Publication date: June 23, 2022
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Udo Hoss, Tianmei Ouyang, Benjamin J. Feldman, Suyue Qian
  • Publication number: 20220192548
    Abstract: The present disclosure provides an analyte sensor for use in detecting potassium. In certain embodiments, an analyte sensor of the present disclosure includes at least two asparagine-responsive active areas, where each asparagine-responsive active area includes an asparaginase that exhibits a particular potassium dependency. In certain embodiments, an analyte sensor of the present disclosure includes at least two aspartate-responsive active areas, where each aspartate-responsive active area includes an aspartate oxidase that exhibits a particular potassium dependency. The present disclosure further provides methods for monitoring potassium levels, e.g., in vivo potassium levels, using the disclosed analyte sensors.
    Type: Application
    Filed: December 23, 2021
    Publication date: June 23, 2022
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Zenghe Liu, Barry S. Kreutz, Yagya Raj Ojha, Benjamin J. Feldman, Thomas P. Leary, Tram Nguyen
  • Publication number: 20220192553
    Abstract: The present disclosure provides an analyte sensor for use in detecting glutamate. In certain embodiments, a glutamate-responsive active site of a presently disclosed analyte sensor includes an enzyme system comprising glutamate dehydrogenase and diaphorase disposed upon a surface of a working electrode. The present disclosure further provides methods for detecting glutamate using the disclosed analyte sensors.
    Type: Application
    Filed: December 23, 2021
    Publication date: June 23, 2022
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Tianmei Ouyang, Benjamin J. Feldman
  • Publication number: 20220183595
    Abstract: Systems, devices and methods are provided for inserting at least a portion of an in vivo analyte sensor for sensing an analyte level in a bodily fluid of a subject. A sensor insertion component may include a small diameter needle disposed at an angle of about 7 to about 10 degrees to a skin normal insertion force vector with a flexible elongate sensor and sharpened tip supported by a U-shaped protector along an intermediate portion. Advancing the needle into the subject along the vector causes stretching of the skin around the needle, allowing entry of the sensor tip into the body. A bump may be provided on a distal portion of the sensor for engagement by the U-shaped protector and transmission of an insertion force to the sensor tip.
    Type: Application
    Filed: December 9, 2021
    Publication date: June 16, 2022
    Inventors: Yi Wang, Hyun Cho, Benjamin J. Feldman, Lam N. Tran, Zahid Sadik
  • Publication number: 20220186277
    Abstract: The present disclosure provides analyte sensors including one or more NAD(P)-dependent enzymes and an internal supply of NAD(P) for the detection of an analyte. The present disclosure further provides methods of using such analyte sensors for detecting one or more analytes present in a biological sample of a subject, and methods of manufacturing said analyte sensors.
    Type: Application
    Filed: December 15, 2021
    Publication date: June 16, 2022
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Tianmei Ouyang, Cade Fox, Zenghe Liu, Stephen Oja, Benjamin J. Feldman
  • Publication number: 20220186278
    Abstract: The present disclosure provides an analyte sensor for use in detecting ketones. In certain embodiments, a ketones-responsive active site of a presently disclosed analyte sensor includes an enzyme system comprising ?-hydroxybutyrate dehydrogenase and NADH oxidase disposed on a surface of a platinum working electrode. The present disclosure further provides methods for detecting ketones using the disclosed analyte sensors.
    Type: Application
    Filed: December 10, 2021
    Publication date: June 16, 2022
    Inventors: Zenghe Liu, Stephen Oja, Tianmei Ouyang, Benjamin J. Feldman
  • Publication number: 20220056500
    Abstract: NADP-dependent oxidoreductase compositions, and electrodes, sensors and systems that include the same. Analyte sensors include an electrode having a sensing layer disposed thereon, the sensing layer comprising a polymer and an enzyme composition distributed therein. The enzyme composition includes nicotinamide adenine dinucleotide phosphate (NAD(P)+) or derivative thereof; an NAD(P)+-dependent dehydrogenase; an NAD(P)H oxidoreductase; and an electron transfer agent comprising a transition metal complex.
    Type: Application
    Filed: August 16, 2021
    Publication date: February 24, 2022
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Tianmei Ouyang, Benjamin J. Feldman
  • Publication number: 20220007978
    Abstract: Analyte sensors are being increasingly employed for monitoring various analytes in vivo. Analyte sensors may feature enhancements to address signals obtained from interferent species. Some analyte sensors may comprise a working electrode comprising an active area disposed thereon and electrode asperities laser planed therefrom. Some analyte sensors may comprise an interferent-reactant species incorporated therewith. Some analyte sensors may comprise an interferent scrubbing electrode. Combinations of these enhancements may additionally be employed.
    Type: Application
    Filed: June 15, 2021
    Publication date: January 13, 2022
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Stephen Oja, Cade Brylee Fox, Lam N. Tran, Zenghe Liu, Benjamin J. Feldman, Udo Hoss, Mark Stephen Yahnke, Tahir S. Khan, Jean-Pierre Babka, Owen Daniel Reynolds
  • Publication number: 20210386340
    Abstract: Analyte sensors are being increasingly employed for monitoring various analytes in vivo. Analyte sensors may feature enhancements to address signals obtained from interferent species. Some analyte sensors may comprise a working electrode having sensing portion and an exposed electrode portion, wherein the sensing portion comprises an active area having an analyte-responsive enzyme disposed thereupon and the exposed electrode portion comprises no active area. The exposed electrode portion and the sensing portion may be present in a ratio of and about 1:10 to about 10:1.
    Type: Application
    Filed: June 15, 2021
    Publication date: December 16, 2021
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Stephen Oja, Benjamin J. Feldman, Lam N. Tran, Jean-Pierre Babka, Mark Stephen Yahnke, Tahir S. Khan, Max Garbett, Adrian Petyt, Mark Alan Schulz, Andrew McGibbon, Andrew James Bull, Udo Hoss
  • Publication number: 20210369155
    Abstract: Analyte sensors featuring an enzyme system comprising diaphorase and a NAD-dependent dehydrogenase may be utilized to detect inhibitors of diaphorase, provided that the transfer of electrons to a working electrode is rate-limiting with respect to the diaphorase. Such analyte sensors may comprise a sensor tail comprising at least a first working electrode, a first active area disposed upon a surface of the first working electrode, and an analyte-permeable membrane overcoating at least the first active area. The enzyme system comprises NAD, reduced NAD, or any combination thereof; a NAD-dependent dehydrogenase, such as NAD-dependent glucose dehydrogenase; and diaphorase. Inhibitors of diaphorase that may be detected include, for example, warfarin, dicoumarol, and similar compounds. A second active area may be present to facilitate detection of an analyte differing from the inhibitor of diaphorase.
    Type: Application
    Filed: May 7, 2021
    Publication date: December 2, 2021
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Benjamin J. Feldman, Tianmei Ouyang, Zenghe Liu, Stephen Oja, Ahmed Hisham Wali, Cade Brylee Fox
  • Publication number: 20210260257
    Abstract: A sensor control device and methods of making them are described. The sensor control device includes an electronics housing and a plug assembly. The electronics housing includes an upper shell matable to a lower mount having a skin-facing surface. The plug assembly is coupled to the electronics housing and includes a sensor module that has a sensor and a sharp module having a sharp. The plug assembly includes a base having a skin-facing surface and a plug portion comprising a lumen therethrough. At least a portion of a surface of the electronics housing or the plug assembly comprises an antimicrobial agent. The antimicrobial agent may be a metal and/or a metal oxide.
    Type: Application
    Filed: February 19, 2021
    Publication date: August 26, 2021
    Inventors: Jonathan D. McCanless, Benjamin J. Feldman